Recruiting Crohns Disease Studies in Iowa City
A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
This is a phase 2b, randomized, double-blind, 3-arm study for the treatment of Crohn's disease. The primary objective of this study is to assess the efficacy of different doses of SAR442970 compared w...
Treatment of Moderate to Severe Refractory Crohn's Disease
This research study is testing an investigational research product called TRX103 as a possible treatment for individuals suffering from Crohn's Disease (CD). The primary purpose of this study is to le...
About Crohns Disease Clinical Trials in Iowa City
Crohn's disease is a chronic inflammatory bowel disease that causes inflammation anywhere in the digestive tract, most commonly in the small intestine and colon. Symptoms include abdominal pain, diarrhea, fatigue, and weight loss. Treatment includes anti-inflammatory drugs, immunosuppressants, biologics, and surgery.
There are currently 2 crohns disease clinical trials recruiting participants in Iowa City, IA. These studies are seeking a combined 121 participants. Research is being sponsored by Sanofi, Tr1X, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Crohns Disease Clinical Trials in Iowa City — FAQ
Are there crohns disease clinical trials in Iowa City?
Yes, there are 2 crohns disease clinical trials currently recruiting in Iowa City, IA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Iowa City?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Iowa City research site will contact you about next steps.
Are clinical trials in Iowa City free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Iowa City studies also compensate for your time and travel.
What crohns disease treatments are being tested?
The 2 active trials in Iowa City are testing new therapies including novel drugs, biologics, and treatment approaches for crohns disease.
Data updated March 2, 2026 from ClinicalTrials.gov